Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Qnovia
AddedFeb 15, 2024
UpdatedJun 18, 2026
Qnovia

Qnovia

Seed

Respira Technologies: Innovating in aerosol science for efficient drug delivery and public health protection.

HQ
Richmond, VA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded as Respira Technologies, Qnovia is a platform pharmaceutical company dedicated to saving lives through innovative inhaled drug delivery systems. The company's core mission is to revolutionize aerosol science to deliver a wide range of pharmaceuticals more effectively. Qnovia's proprietary inhalation-based technology aims to overcome the limitations of traditional drug delivery methods, offering a versatile platform with applications that can significantly impact public health.

Qnovia has attracted notable investors and industry experts who support its groundbreaking approach to drug delivery. The company has achieved significant milestones in developing its technology, which has the potential to transform how medications are administered for various conditions. By focusing on both medical and consumer health applications, Qnovia is poised to make a substantial impact on global health outcomes.

Qnovia - Similar Companies

Respira Therapeutics logo

Respira Therapeutics

BioQ Pharma logo

BioQ Pharma

bioqpharma.com

Respirogen logo

Respirogen

respirogen.com

Transpire Bio logo

Transpire Bio

transpirebio.com

Respirics logo

Respirics

Pneuma Respiratory logo

Pneuma Respiratory

Qatch Technologies logo

Qatch Technologies

qatchtech.com

Pure Scientific Technologies logo

Pure Scientific Technologies

Respira Labs logo

Respira Labs

Qrativ logo

Qrativ

qrativ.bio

Kinaset Therapeutics logo

Kinaset Therapeutics

kinasettx.com

Quinnova Pharmaceuticals logo

Quinnova Pharmaceuticals

quinnova.com

Miist Therapeutics logo

Miist Therapeutics

mymiist.com

QbDVision logo

QbDVision

qbdvision.com

Inhalon Biopharma logo

Inhalon Biopharma

inhalon.com

Qnovia - Quick Facts

Who are Qnovia's competitors?

Companies similar to Qnovia include Respira Therapeutics, BioQ Pharma, Respirogen and Transpire Bio.

When was Qnovia founded?

Qnovia was founded in 2018.

Where is Qnovia's headquarters located?

Qnovia's headquarters is located in Richmond, VA, US.

When was Qnovia's last funding round?

Qnovia's most recent funding round was for $2.9M (USD) in June 2023.

How much has Qnovia raised to-date?

As of Jun 7, 2023, Qnovia has raised a total of $22.5M (USD).

How many employees does Qnovia have?

Qnovia has 8 employees as of Feb 5, 2024.

Qnovia - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified